VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 132 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,012,921 | -6.8% | 465,954 | +42.2% | 0.01% | 0.0% |
| Q2 2023 | $2,159,345 | +33.6% | 327,670 | +37.6% | 0.01% | +28.6% |
| Q1 2023 | $1,616,869 | +220.1% | 238,125 | +248.4% | 0.01% | +250.0% |
| Q4 2022 | $505,158 | -26.8% | 68,357 | -2.2% | 0.00% | -50.0% |
| Q3 2022 | $690,000 | -11.9% | 69,876 | -2.8% | 0.00% | 0.0% |
| Q2 2022 | $783,000 | -16.0% | 71,876 | -12.8% | 0.00% | 0.0% |
| Q1 2022 | $932,000 | -27.9% | 82,395 | 0.0% | 0.00% | -20.0% |
| Q4 2021 | $1,293,000 | -8.4% | 82,395 | +0.0% | 0.01% | -16.7% |
| Q3 2021 | $1,412,000 | +21.7% | 82,370 | +52.7% | 0.01% | +20.0% |
| Q2 2021 | $1,160,000 | +27.3% | 53,949 | -11.1% | 0.01% | +25.0% |
| Q1 2021 | $911,000 | -24.2% | 60,679 | -33.7% | 0.00% | -20.0% |
| Q4 2020 | $1,202,000 | +34.2% | 91,478 | -1.3% | 0.01% | +25.0% |
| Q3 2020 | $896,000 | -47.9% | 92,703 | -38.3% | 0.00% | -50.0% |
| Q2 2020 | $1,720,000 | -21.6% | 150,364 | -29.0% | 0.01% | -42.9% |
| Q1 2020 | $2,193,000 | -51.3% | 211,632 | -22.8% | 0.01% | -36.4% |
| Q4 2019 | $4,501,000 | +45.2% | 274,274 | +17.5% | 0.02% | +29.4% |
| Q3 2019 | $3,100,000 | +520.0% | 233,414 | +558.2% | 0.02% | +466.7% |
| Q2 2019 | $500,000 | -27.0% | 35,462 | -4.7% | 0.00% | -25.0% |
| Q1 2019 | $685,000 | -68.2% | 37,202 | -54.8% | 0.00% | -69.2% |
| Q4 2018 | $2,152,000 | -0.6% | 82,352 | -12.7% | 0.01% | +18.2% |
| Q3 2018 | $2,165,000 | +201.1% | 94,342 | +150.1% | 0.01% | +175.0% |
| Q2 2018 | $719,000 | +13.1% | 37,722 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $636,000 | +11.4% | 37,722 | +0.3% | 0.00% | +33.3% |
| Q4 2017 | $571,000 | +106.1% | 37,597 | +142.7% | 0.00% | +50.0% |
| Q3 2017 | $277,000 | -18.5% | 15,492 | -63.2% | 0.00% | -60.0% |
| Q2 2013 | $340,000 | – | 42,058 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,532,000 | $27,423,000 | 3.23% |
| Stonepine Capital Management, LLC | 300,000 | $5,370,000 | 3.16% |
| Palo Alto Investors LP | 4,155,670 | $74,386,000 | 3.13% |
| GREAT POINT PARTNERS LLC | 497,531 | $8,906,000 | 1.73% |
| Avoro Capital Advisors LLC | 988,270 | $17,690,000 | 1.37% |
| UNIVERSITY OF NOTRE DAME DU LAC | 157,781 | $2,824,000 | 0.79% |
| Birchview Capital, LP | 68,000 | $1,217,000 | 0.63% |
| Cheyne Capital Management (UK) LLP | 74,000 | $1,323,000 | 0.48% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 352,604 | $6,311,000 | 0.43% |
| 361 CAPITAL LLC | 119,554 | $2,140,000 | 0.41% |